{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:06:39Z","timestamp":1781625999541,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      infection might result in fatal outcome in patients with haematologic malignancies or those with primary or iatrogenic immunodefects. However, in countries with low tuberculosis (TB) incidence the awareness for TB is still challenging, with an increasing need due to migrating populations from regions with high TB to low TB incidence countries.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report and epidemiological analysis<\/jats:title>\n                    <jats:p>\n                      A 52-year-old caucasian female, refugee from Afghanistan, presented at University Hospital Charit\u00e9 (Berlin, Germany) with progressive left-sided hearing loss due to ear canal obstruction as well as right axillary exophytic and ulcerating skin lesions, finally diagnosed as\n                      <jats:italic>BRAF<\/jats:italic>\n                      -V600E-mutated Langerhans cell histiocytosis (LCH). Following systemic chemotherapy, LCH showed complete remission (CR) with however unexpectedly progressive left-axillary lymphadenopathy. Biopsy of these lymph nodes revealed granulomatous inflammation with central caseous necroses.\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      DNA was undetectable in a biopsy from the lesion, but culture of fresh re-biopsy material showed growth of\n                      <jats:italic>M. tuberculosis<\/jats:italic>\n                      . Given the patient\u00b4s migration history from a high-prevalence (Afghanistan) to a low-prevalence (Germany) TB country, we also present the long-time trend of the total number of TB patients notified in Germany in 2002\u20132023, i.e. a total of 21\u2009years, aggregated by country of birth. Whereas the number of TB patients born in Germany is decreasing since 2002, the number of patients born abroad exceeded the number of those born in Germany in 2012, and remained higher ever since.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our report highlights the challenge to treat patients at the crossroads of malignancy and TB, and the need for appropriate attention and awareness of physicians of the increased TB risk in people migrating from a high- to a low-burden TB country. Also, the case demonstrates once more the high value of culture for diagnosis of mycobacteria infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12043-6","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T12:16:44Z","timestamp":1766492204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["At the crossroads of infection and malignancy: the challenge of tuberculosis in migrating populations \u2013 Case Report and Epidemiologic Analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Hans-J\u00f6rg","family":"Epple","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Domaszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Christin von","family":"Br\u00fcnneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Dommerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinah von","family":"Sch\u00f6ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Maschmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"B\u00f6s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9626-1413","authenticated-orcid":false,"given":"Stephan","family":"Mathas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"12043_CR1","doi-asserted-by":"publisher","unstructured":"Bergeron A, Mikulska M, De Greef J, et al. Mycobacterial infections in adults with haematologic malignancies and haematopoieic stem cell transplants: guidelines from the 8th. European Conference on Infections in Leukemia. Lancet Infect Dis. 2022:e359\u201369. [PMID: 35636446]. https:\/\/doi.org\/10.1016\/S1473-3099(22)00227-4.;22.","DOI":"10.1016\/S1473-3099(22)00227-4.;22"},{"key":"12043_CR2","unstructured":"World Health Organization. Who global list of high burden countries for tuberculosis, TB\/HIV and multidrug\/rifampicin-resistant tb (MDR\/RR-TB). 2021-2025. 2021."},{"key":"12043_CR3","doi-asserted-by":"publisher","first-page":"2401612","DOI":"10.1183\/13993003.01612-2024","volume":"65","author":"H Kunst","year":"2025","unstructured":"Kunst H, Lange B, Hovardovska O, et al. Tuberculosis in adult migrants in Europe: a TBnet consensus statement. Eur Respir J. 2025;65:2401612. [PMID: 39672603]. https:\/\/doi.org\/10.1183\/13993003.01612-2024.","journal-title":"Eur Respir J"},{"key":"12043_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1473-3009(17)30703-X","volume":"18","author":"GBD Tuberculosis Collaborators","year":"2018","unstructured":"GBD Tuberculosis Collaborators. The global burden of tuberculosis: results from the global burden of disease study 2015. Lancet Infect Dis. 2018;18:261\u201384. [PMID: 29223583]. https:\/\/doi.org\/10.1016\/S1473-3009(17)30703-X.","journal-title":"Lancet Infect Dis"},{"key":"12043_CR5","doi-asserted-by":"publisher","first-page":"1900896","DOI":"10.1183\/13993003.00896-2019","volume":"54","author":"S Villa","year":"2019","unstructured":"Villa S, Codecasca LR, Faccini M, et al. Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions. Eur Resp J. 2019;54:1900896. [PMID: 31413161]. https:\/\/doi.org\/10.1183\/13993003.00896-2019.","journal-title":"Eur Resp J"},{"key":"12043_CR6","unstructured":"Koch R. \u00dcber bakteriologische Forschung. In: Verhandlungen des X. Internationalen Medizinischen Kongresses, Berlin. Band I; 1890. Verlag August Hirschwald, Berlin 1891p. 650\u201360."},{"key":"12043_CR7","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1182\/blood.2021014343","volume":"139","author":"G Goyal","year":"2022","unstructured":"Goyal G, Tazi A, Go RS, et al. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood. 2022;139:2601\u201321. [PMID: 35271698]. https:\/\/doi.org\/10.1182\/blood.2021014343.","journal-title":"Blood"},{"key":"12043_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s002920050391","volume":"21","author":"C Schewe","year":"2000","unstructured":"Schewe C, Rizzello M, Dietel M, et al. Zur PCR-basierten Erregerdiagnostik in der Pathologie. Pathologe. 2000;21:218\u201328. [PMID 10900614]. https:\/\/doi.org\/10.1007\/s002920050391.","journal-title":"Pathologe"},{"key":"12043_CR9","volume-title":"Who consolidated guidelines on tuberculosis. Module 4: treatment \u2013 drug-susceptible tuberculosis treatment","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Who consolidated guidelines on tuberculosis. Module 4: treatment \u2013 drug-susceptible tuberculosis treatment. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"12043_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1055\/a-1934-8303","volume":"76","author":"T Schaberg","year":"2022","unstructured":"Schaberg T, Brinkmann F, Feiterna-Sperling C, et al. Tuberculosis in adulthood \u2013 the Sk2-guideline of the German central committee against tuberculosis (DZK) and the German respiratory society (DGP) for the diagnosis and treatment of adult tuberculosis patients. Pneumologie. 2022;76:727\u2013819. [PMID 36384164]. https:\/\/doi.org\/10.1055\/a-1934-8303.","journal-title":"Pneumologie"},{"key":"12043_CR11","unstructured":"Global Programme on Tuberculosis and Lung Health (GTB). 2025. https:\/\/www.who.int\/publications\/i\/item\/9789240107243."},{"key":"12043_CR12","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1164\/rccm.201909-1874ST","volume":"200","author":"P Nahid","year":"2019","unstructured":"Nahid P, Mase SR, Migliori GB, et al. Treatment of drug-resistant tuberculosis. An official ATS\/CDC\/ERS\/IDSA clinical practice guideline. Am J Respir Crit Care Med. 2019;200:e93\u2013142. [PMID 31729908]. https:\/\/doi.org\/10.1164\/rccm.201909-1874ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"12043_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1182\/blood-2014-12-569301","volume":"126","author":"CE Allen","year":"2015","unstructured":"Allen CE, Ladisch S, McClain KL. How I treat Langerhans cell histiocytosis. Blood. 2015;126:26\u201335. [PMID 25827831]. https:\/\/doi.org\/10.1182\/blood-2014-12-569301.","journal-title":"Blood"},{"key":"12043_CR14","unstructured":"https:\/\/worldhealthorg.shinyapps.io\/tb_profiles\/?_inputs_&tab=%22tables%22&lan=%22EN%22&iso2=%22AF%22&entity_type=%22country%22."},{"key":"12043_CR15","unstructured":"https:\/\/www.rki.de\/DE\/Themen\/Infektionskrankheiten\/Infektionskrankheiten-A-Z\/T\/Tuberkulose\/Download\/TB2023.pdf?__blob=publicationFile&v=3."},{"key":"12043_CR16","unstructured":"Gesetz zur Modernisierung der epidemiologischen \u00dcberwachung \u00fcbertragbarer Krankheiten. In: Bundesgesetzblatt Jahrgang2017 Teil I Nr 49 [Internet]. 2017 [cited 2019 May 13]. Available from.https:\/\/www.bgbl.de\/xaver\/bgbl\/start.xav?start=%2F%2F*%5B%40attr_id%3D%27bgbl117s2615.pdf%27%5D#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl117s2615.pdf%27%5D__1557757957459."},{"key":"12043_CR17","doi-asserted-by":"publisher","unstructured":"Sconocchia T, Fo\u00dfelteder J, Sconocchia G, et al. Langerhans cell histiocytosis: current advances in molecular pathogenesis. Front Immunol. 2023;14:1275085. [PMID: 37965340]. https:\/\/doi.org\/10.3389\/fimmu.2023.1275085.","DOI":"10.3389\/fimmu.2023.1275085"},{"key":"12043_CR18","doi-asserted-by":"publisher","unstructured":"Feng C, Li Y, Ke H, et al. Immune microenvironment in langerhans cell histiocytosis: potential prognostic indicators. Front Oncol. 2021;11:631682. [PMID 34026610]. https:\/\/doi.org\/10.3389\/fonc.2021.631682.","DOI":"10.3389\/fonc.2021.631682"},{"key":"12043_CR19","doi-asserted-by":"publisher","first-page":"e0195924","DOI":"10.1128\/jcm.01959-24","volume":"14","author":"U Eigner","year":"2025","unstructured":"Eigner U, K\u00f6ffer J, Betz U, et al. Evaluation of the cobas MTB and MTB-RIF\/INH assay in clinical samples for the detection of mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol. 2025;14:e0195924. [PMID: 40130921]. https:\/\/doi.org\/10.1128\/jcm.01959-24.","journal-title":"J Clin Microbiol"},{"key":"12043_CR20","doi-asserted-by":"publisher","first-page":"116385","DOI":"10.1016\/j.diagmicrobio.2024.116385","volume":"110","author":"L Dai","year":"2024","unstructured":"Dai L, Peng L, Fang T, et al. Diagnostic performance analysis of xpert MTB\/RIF in lymph node tuberculosis: a retrospective study. Diagn Microbiol Infect Dis. 2024;110:116385. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116385.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"12043_CR21","doi-asserted-by":"publisher","unstructured":"Kohli M, Schiller I, Denukuri N, et al. Xpert MTB\/RIF ultra and xpert MTB\/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2021;1:CD012768. [PMID: 33448348]. https:\/\/doi.org\/10.1002\/14651858.CD012768.pub3.","DOI":"10.1002\/14651858.CD012768.pub3"},{"key":"12043_CR22","unstructured":"https:\/\/register.awmf.org\/assets\/guidelines\/020-019l_S2k_Tuberkulose-im-Erwachsenenalter_2023-09.pdf."},{"key":"12043_CR23","unstructured":"https:\/\/innovationsfonds.g-ba.de\/projekte\/versorgungsforschung\/tb-risk.511."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12043-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12043-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12043-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:39:20Z","timestamp":1781624360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12043-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12043"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12043-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient case: Ethics declaration: Not applicable. Informed consent of the LCH patient was obtained prior to submission. Epidemiological data: The German national TB-surveillance data utilized in this study are routinely collected under the Robert Koch Institute\u00b4s legal mandate for national surveillance of infectious diseases in Germany, for the notification data in accordance with the German Protection again Infection law (Infektionsschutzgesetz). Data collected under this surveillance mandate are pseudonymized and no personal identifiable information such as names, personal or health IDs, or exact birth dates are collected. Therefore, ethics approval and consent to participate were deemed not necessary for the analysis of the German TB-surveillance data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"Written informed consent of the patient was obtained prior to submission. The German national TB-surveillance data utilized in this study are routinely collected under the Robert Koch Institute\u00b4s legal mandate for national surveillance of infectious diseases in Germany, and no consent for publication for the use of these pseudonymized data is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}